Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia | Zendy

Cristina Eller-Vainicher | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia

Author(s) -

Cristina Eller-Vainicher

Publication year - 2016

Publication title -

clinical cases in mineral and bone metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.314

H-Index - 32

eISSN - 1971-3266

pISSN - 1724-8914

DOI - 10.11138/ccmbm/2016.13.3.253

Subject(s) - denosumab , medicine , bone remodeling , n terminal telopeptide , bone resorption , craniofacial , bone pain , osteocalcin , surgery , urology , osteoporosis , alkaline phosphatase , chemistry , biochemistry , psychiatry , enzyme

We report on the clinical and biochemical outcomes in a 20-year-old male suffering from active craniofacial monostotic fibrous dysplasia (MFD) of the left mandible treated with the RANK-L inhibitor, denosumab, following unsatisfactory responses to prior long-term bisphosphonates therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research